fident they aren't a
steroid responder. He
says a compounded
combination of dex-
amethasone, moxi-
floxacin and ketorolac
delivered intracamer-
ally is a cost-effective
option — approxi-
mately $25 per case. In
comparison, a branded
nonsteroidal and
fourth generation fluo-
roquinolone could cost
upwards of $300.
Administering intracameral injections at the time of surgery elimi-
nates the need for physicians to call in post-op prescriptions and the
treatment is also more convenient for patients, who don't have to ven-
ture out to pharmacies to pick up prescriptions. "It's pretty appealing
— there are no worries about compliance and you remove a burden
of care for patients, says Dr. Hovanesian.
Limiting the burden
Surgeons can opt to prescribe a combination of prednisolone acetate,
moxifloxacin and bromfenac in a single bottle, eliminating the need
for patients to administer several drops daily. Dr. Hoffman prescribes
patients prednisone, nonsteroidal anti-inflammatory drugs and antibi-
otics in a combination drop, whenever possible.
A recent study compared the outcomes of a standard three-drop regi-
men with a combination drop containing gatifloxacin, bromfenac and
9 8 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • M A R C H 2 0 2 0
• POINT OF CARE Injecting steroids or antibiotics at the time of surgery can elimi-
nate burdensome drop regimens.
